ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LPL Financial LLC | 3,236 | $303,019 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 6,639 | $621,676 | 0.00% |
| Citadel Advisors | 18,700 | $1,751,068 | 0.00% |
| Citadel Advisors | 14,300 | $1,339,052 | 0.00% |
| Citadel Advisors | 248 | $23,223 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 19,330 | $1,810,061 | 0.00% |
| Washington Trust Advisors, Inc. | 38 | $3,559 | 0.00% |
| Bogart Wealth, LLC | 34 | $3,184 | 0.00% |
| Coppell Advisory Solutions LLC | 76 | $136 | 0.00% |
| Financial Gravity Asset Management, Inc. | 2 | $147 | 0.00% |
| PEAK6 Investments LLC | 500 | $46,820 | 0.00% |
| Walleye Capital LLC | 1,900 | $177,916 | 0.00% |
| US BANCORP \DE\ | 210 | $19,665 | 0.00% |
External links
This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.